Treatment of pediatric relapsed and refractory acute myeloid leukemia
Background. Despite the modern therapy programs including hematopoietic stem cell transplantation, the treatment outcomes for children with acute myeloid leukemia (AML) remain unsatisfactory. The 5‑year overall survival rate is about 70 %. The 5‑year overall survival rate for patients with relapsed...
Saved in:
| Main Authors: | F. A. Makhacheva, T. T. Valiev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-05-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric acute myeloid leukemias treatment: current scientific view
by: F. A. Makhacheva, et al.
Published: (2020-04-01) -
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
by: SV Gritsaev, et al.
Published: (2016-01-01) -
Clinical features of secondary acute myeloid leukemia in children
by: F. A. Makhacheva, et al.
Published: (2020-12-01) -
Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
by: G. A. Radzhabova, et al.
Published: (2025-03-01) -
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
by: Bhavana Bhatnagar, et al.
Published: (2025-04-01)